ARTICLE | Company News
AVI other research news
December 11, 2000 8:00 AM UTC
AVII said that a Neugene antisense compound against TGF-beta accelerated engraftment of transplanted treated hematopoietic stem cells and reduced the number of stem cells required to rescue a lethally...